HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 529-540 of 1,979
Drug study icon
WithdrawnNCT01685151

Ramelteon Tablets for Bipolarity

Official study title

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375SL as an Adjunctive Therapy to Treatment-as-Usual in the Maintenance Treatment of Bipolar 1 Disorder in Adult Subjects

This study was withdrawn before enrollment.

Location not clearly listed
BipolarityMedication studyAges 18–75
Countries
Sponsor
Takeda
Drug study icon
CompletedNCT00261443

Aripiprazole (Abilify) in people with Bipolar Mania

Official study title

Efficacy of Aripiprazole in Combination With Lithium or Valproate in the Long-Term Maintenance Treatment of Bipolar I Disorder in Outpatients Partially Nonresponsive to Lithium or Valproate Monotherapy

This study has finished and is no longer accepting participants.

Multiple locations, including Tuscaloosa
BipolarityMedication studyAges 18+
Countries
United States, France, Brazil, + 6 others
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Other study type icon
CompletedNCT00741299

The Association Between Tobacco Smoking and Bipolarity

Official study title

Association Between Tobacco Smoking and Bipolar Affective Disorder.Clinico-epidemiological, Cross-sectional, Retrospective Study.

This study has finished and is no longer accepting participants.

In Tirat HaCarmel
BipolarityObservational studyAges 18–65
Countries
Israel
Sponsor
Tirat Carmel Mental Health Center
Drug study icon
CompletedNCT01092221

Allopurinol for Mania: A study Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode

Official study title

Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode.

This study has finished and is no longer accepting participants.

Multiple locations, including Beer-Yaakov
BipolarityMedication studyAges 18–65
Countries
Israel, Romania
Sponsor
Sheba Medical Center
Behavioral study icon
CompletedNCT06296784

An E-health Psychoeducation for People With Bipolarity

Official study title

An E-health Psychoeducation Program to Manage Symptoms During COVID-19 Pandemic for People With Bipolar Disorders: a Randomized Controlled Study

This study has finished and is no longer accepting participants.

In Cagliari
BipolarityInterventional studyAges 18+
Countries
Italy
Sponsor
University of Cagliari
Drug study icon
CompletedNCT00095511

Aripiprazole in people with Acute Mania

Official study title

A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Aripiprazole Monotherapy in the Treatment of Acutely Manic Patients With Bipolar I Disorder

This study has finished and is no longer accepting participants.

Multiple locations, including Tuscaloosa
BipolarityMedication studyAges 18+
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
TerminatedNCT06423794

BHV-7000 Extension Bipolar Mania Study

What is this study about?

Researchers are studying BHV-7000, tracking side effects to assess long-term safety and tolerability in people with bipolarity type I.

This study ended early.

Multiple locations, including Bentonville
BipolarityMedication studyAges 18–75
Countries
United States
Sponsor
Biohaven Therapeutics Ltd.
Behavioral study icon
CompletedNCT01176825

Cognitive-Behavior Therapy for Young Adults With Bipolarity

Official study title

Reducing High-Risk Behaviors Among Bipolar Patients Transitioning to Adulthood

This study has finished and is no longer accepting participants.

In Boston
BipolarityBehavioural studyAges 18–24
Countries
United States
Sponsor
Massachusetts General Hospital (Hospital / academic medical center)
Drug study icon
CompletedNCT00000439

Drug Treatment for Alcoholics With Bipolarity

Official study title

Efficacy of Valproate Maintenance in Bipolar Alcoholics

This study has finished and is no longer accepting participants.

In Pittsburgh
BipolarityMedication studyAges 18–65
Countries
United States
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Other study type icon
CompletedNCT06167577

Dysbindin-antipsychotics Psychophamarcogenetics: a Mouse-human Translational Study Towards Personalized Healthcare in Bipolarity

Official study title

Dysbindin-antipsychotics Psychophamarcogenetics: a Mouse-human Translational Study Towards Personalized Healthcare in Bipolar Disorders GR-2016-02362413

This study has finished and is no longer accepting participants.

In Milan
BipolarityObservational studyAges 18–65
Countries
Italy
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.